Table 1:
Medication | Occurrences | Metabolic Pathway(s) |
---|---|---|
| ||
Trazodone | 34 | CYP3A4 |
Gabapentin | 33 | Not metabolized |
Levothyroxine | 25 | Not significant CYP450 |
Atorvastatin | 22 | CYP3A4 |
Duloxetine | 21 | CYP1A2, CYP2D6 |
Bupropion | 20 | CYP2B6, also inhibits CYP2D6 |
Clonazepam | 17 | CYP3A4 |
Pantoprazole | 17 | CYP2C19 |
Quetiapine | 16 | CYP3A4 |
Metformin | 13 | Not metabolized |
Buspirone | 13 | CYP3A4 |
Prazosin | 12 | Not significant CYP450 |
Lisinopril | 12 | Not metabolized |
Aripiprazole | 12 | CYP2D6, CYP3A4 |
Metoprolol | 11 | CYP2D6 |
Venlafaxine | 11 | CYP2D6 |
Montelukast | 10 | CYP2C8 |
Omeprazole | 10 | CYP2C19 |
Lorazepam | 10 | Not significant CYP450 |
Amlodipine | 10 | CYP3A4 |
Lamotrigine | 9 | Not significant CYP450 |
Losartan | 8 | CYP2C9, CYP3A4 |
Mirtazapine | 8 | Minor CYP2D6, CYP1A2, CYP3A4 |
Topiramate | 7 | Not CYP450 |
Lurasidone | 7 | CYP3A4 |